April 11, 2008 -- China YCT International Group Inc. (OTCBB: CYIG) announced an unusually complex agreement between its China subsidiary, Shandong Spring Pharmaceutical Co., Ltd, and a second company with which it shares some history, Shandong Yong Chun Tang Bioengineering Co. Ltd. The two companies have signed an Entrusted Management Agreement under which Shandong Spring will manage the operations of Shandong Yong Chun Tang in exchange for all of the latter’s net profits. More details...
